TY - JOUR
T1 - Influence of peroxisome proliferator-activated receptor α on ubiquinone biosynthesis
AU - Turunen, Mikael
AU - Peters, Jeffrey M.
AU - Gonzalez, Frank J.
AU - Schedin, Sophia
AU - Dallner, Gustav
N1 - Funding Information:
This work was supported by the Swedish Cancer Society and the Swedish Medical Research Council.
PY - 2000/3/31
Y1 - 2000/3/31
N2 - The control of ubiquinone biosynthesis by peroxisome proliferators was investigated using peroxisome proliferator activated receptor α (PPARα)-null mice. Administration of 2-(diethylhexyl)phthalate to control mice resulted in elevated ubiquinone levels in the liver, while dolichol, dolichyl-P and cholesterol concentrations remained unchanged. In PPARα-null mice, the level of these lipids were similar to control levels and administration of the peroxisome proliferator did not increase the levels of ubiquinone. The increase in ubiquinone levels was the result of increased synthesis. Induction was most pronounced in liver, kidney and heart, which have relatively high levels of PPARα. When the tissue concentration of hydrogen peroxide was elevated by inhibition of catalase activity with aminotriazole, the amount of ubiquinone was not increased, suggesting that the induction of ubiquinone synthesis occured through a direct mechanism. The activities of branch-point enzymes FPP-synthase, squalene synthase, cis-prenyltransferase, trans-prenyltransferase and NPHB-transferase were substantially increased in control but not in PPARα-null mice after treatment with peroxisome proliferators. These data suggest that the induction of ubiquinone biosynthesis after administration of peroxisome proliferators is dependent on the PPARα through regulation of some of the mevalonate pathway enzymes. (C) 2000 Academic Press.
AB - The control of ubiquinone biosynthesis by peroxisome proliferators was investigated using peroxisome proliferator activated receptor α (PPARα)-null mice. Administration of 2-(diethylhexyl)phthalate to control mice resulted in elevated ubiquinone levels in the liver, while dolichol, dolichyl-P and cholesterol concentrations remained unchanged. In PPARα-null mice, the level of these lipids were similar to control levels and administration of the peroxisome proliferator did not increase the levels of ubiquinone. The increase in ubiquinone levels was the result of increased synthesis. Induction was most pronounced in liver, kidney and heart, which have relatively high levels of PPARα. When the tissue concentration of hydrogen peroxide was elevated by inhibition of catalase activity with aminotriazole, the amount of ubiquinone was not increased, suggesting that the induction of ubiquinone synthesis occured through a direct mechanism. The activities of branch-point enzymes FPP-synthase, squalene synthase, cis-prenyltransferase, trans-prenyltransferase and NPHB-transferase were substantially increased in control but not in PPARα-null mice after treatment with peroxisome proliferators. These data suggest that the induction of ubiquinone biosynthesis after administration of peroxisome proliferators is dependent on the PPARα through regulation of some of the mevalonate pathway enzymes. (C) 2000 Academic Press.
UR - http://www.scopus.com/inward/record.url?scp=0034737322&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034737322&partnerID=8YFLogxK
U2 - 10.1006/jmbi.2000.3596
DO - 10.1006/jmbi.2000.3596
M3 - Article
C2 - 10731415
AN - SCOPUS:0034737322
SN - 0022-2836
VL - 297
SP - 607
EP - 614
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 3
ER -